Your browser doesn't support javascript.
loading
Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study).
Kato, Sawako; Kuwatsuka, Yachiyo; Ando, Masahiko; Tatematsu, Yoshitaka; Nishibori, Nobuhiro; Maruyama, Shoichi.
Afiliação
  • Kato S; Department of Nephrology, Nagoya University Graduate School of Medicine, 65, Tsuruma-Cho, Showa-Ku, Nagoya, Aichi, 464-8550, Japan. kato07@med.nagoya-u.ac.jp.
  • Kuwatsuka Y; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
  • Ando M; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
  • Tatematsu Y; Department of Nephrology, Nagoya University Graduate School of Medicine, 65, Tsuruma-Cho, Showa-Ku, Nagoya, Aichi, 464-8550, Japan.
  • Nishibori N; Department of Nephrology, Nagoya University Graduate School of Medicine, 65, Tsuruma-Cho, Showa-Ku, Nagoya, Aichi, 464-8550, Japan.
  • Maruyama S; Department of Nephrology, Nagoya University Graduate School of Medicine, 65, Tsuruma-Cho, Showa-Ku, Nagoya, Aichi, 464-8550, Japan.
BMC Nephrol ; 24(1): 228, 2023 08 03.
Article em En | MEDLINE | ID: mdl-37537531
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article